The following datasets were analyzed to confirm the expression of KIF2C in patients with ALL—pediatric ALL-Phase II (TARGET, 2018), TARGET_paired sample consisting of data from only paired samples extracted from the TARGET cohort, GSE60926 and GSE28460. Here, KIF2C is linked to acute lymphoblastic leukemia.